ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01148498
Previous Study | Return to List | Next Study

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01148498
Recruitment Status : Completed
First Posted : June 22, 2010
Last Update Posted : September 25, 2012
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2012
  Actual Study Completion Date : August 2012
  Certification/Extension First Submitted : September 18, 2012